Skip to main content

Table 2 Comparison of early termination and on-schedule completion of RRT in the AN69 and AN69ST groups

From: Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study

 

RRT completed on schedule

RRT early terminated

RRT time (min)

543.1 ± 118.9

 

387.3 ± 140.8

 
 

AN69

AN69 ST

P value

AN69

AN69 ST

P value

 

567.1 ± 119.9

548.3 ± 128.2

NS

366.9 ± 139.7

404.8 ± 142.0

NS

BFR ml/min

205.2 ± 16.9

202.4 ± 10.9

NS

206.5 ± 22.9

206.2 ± 22.8

NS

UF ml

2161.9 ± 908.0

2142.9 ± 1073.6

NS

1795.8 ± 1204.1

1751.8 ± 948.7

NS

Before RRT

 PLT X10^9

115.9 ± 83.0

108.7 ± 71.7

NS

145.5 ± 109.2

132.4 ± 73.5

NS

 Hb g/L

83.1 ± 10.4

81.7 ± 14.3

NS

90.8 ± 13.6

87.4 ± 15.0

NS

 WBC X10^9

9.37 ± 4.58

9.46 ± 4.81

NS

11.8 ± 13.8

10.9 ± 6.8

NS

 PT s

13.71 ± 4.91

13.25 ± 3.65

NS

13.2 ± 1.7

13.0 ± 2.2

NS

 APTT s

42.41 ± 20.80

42.71 ± 30.0

NS

36.2 ± 9.9

34.4 ± 11.2

NS

 ALB g/L

31.3 ± 4.16

32.0 ± 4.1

NS

28.4 ± 5.9

28.5 ± 4.3

NS

 SCr umol/L

356.1 ± 260.5

402.0 ± 288.8

NS

338.9 ± 175.0

381.0 ± 251.3

NS

 BUN mmol/L

19.24 ± 9.00

21.70 ± 7.53

NS

20.6 ± 8.7

21.2 ± 10.0

NS

After RRT

 PLT

93.7 ± 57.7

100.6 ± 67.7

NS

152.6 ± 106.0

125.2 ± 68.1

NS

 Hb

84.7 ± 13.4

83.3 ± 14.8

NS

89.9 ± 15.1

86.8 ± 17.9

NS

 WBC X10^9

8.94 ± 5.16

8.22 ± 4.40

NS

8.81 ± 4.62

10.3 ± 5.4

NS

 PT

13.63 ± 4.22

13.00 ± 2.86

NS

13.0 ± 1.8

13.4 ± 4.1

NS

 APTT

48.5 ± 44.01

34.78 ± 6.16

NS

33.7 ± 9.3

30.1 ± 5.1

NS

 ALB

33.8 ± 4.7

33.9 ± 4.5

NS

28.2 ± 5.6

29.4 ± 5.5

NS

 SCr

241.7 ± 186.4

252.5 ± 199.4

NS

260.1 ± 151.8

279.2 ± 179.8

NS

 BUN

12.5 ± 5.8

21.1 ± 31.6

NS

15.2 ± 7.1

15.9 ± 7.8

NS

clotting grades of filters 0/1/2/3

2/7/8/12

5/10/5/10

 

0/0/1/23

0/2/2/23

 

Vein well cloting 0/1

29/1

29/1

 

22/2

24/3